Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993.
about
Psychosis and autism as diametrical disorders of the social brainThe emergence of human-evolutionary medical genomicsCancer in patients with schizophrenia: What is the next step?Using the literature-based discovery paradigm to investigate drug mechanismsPolymorphisms of XRCC4 are involved in reduced colorectal cancer risk in Chinese schizophrenia patients.Cancer and schizophrenia: is there a paradox?Autism and cancer risk.Psychiatric disorder as a risk factor for cancer: different analytic strategies produce different findings.Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?Schizophrenia, cancer and obstetric complications in an evolutionary perspective-an empirically based hypothesisExcess non-psychiatric hospitalizations among employees with mental disorders: a 10-year prospective study of the GAZEL cohort.Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis.Cancer risk among users of neuroleptic medication: a population-based cohort study.Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997-2009.Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden.A review of the association between antipsychotic use and hyperprolactinaemia.Antipsychotics and hyperprolactinaemia: clinical recommendations.Adverse effects of prolactin in rodents and humans: breast and prostate cancer.Hyperprolactinaemia during treatment with paliperidone.Schizophrenia and cancer: in 2010 do we understand the connection?Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders.Lithium and renal and upper urinary tract tumors - results from a nationwide population-based study.Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.Dopamine D2 receptor blocker thioridazine induces cell death in human uterine cervical carcinoma cell line SiHa.Mortality in first-contact psychosis patients in the U.K.: a cohort study.Substantial skin disorders in psychiatric illness coincide with diabetes and addiction.Excess cancer mortality in psychiatric patients.Cancer incidence in patients with schizophrenia and their first-degree relatives - a meta-analysis.Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies.Lower risk of liver cancer in patients with schizophrenia: a systematic review and meta-analysis of cohort studies.A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma.DR2 blocker thioridazine: A promising drug for ovarian cancer therapy.Why do psychiatric patients have higher cancer mortality rates when cancer incidence is the same or lower?The emerging physical health challenges of antipsychotic associated hyperprolactinaemia in patients with serious mental illness.Association of Schizophrenia With the Risk of Breast Cancer Incidence: A Meta-analysis.A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemiaThe anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancerSerotonin receptor type 1B constitutes a therapeutic target for MDS and CMMLGlioma in Schizophrenia: Is the Risk Higher or Lower?
P2860
Q28285118-4103CA32-1AC9-48CE-B771-09F83C237C43Q28729955-6A05A6AA-AD38-46BA-847B-065B95AB4978Q30249107-DE169104-B6B5-48A0-8E22-16240D217807Q33359167-189A0BB2-56BF-4067-A8C3-8607B41FC5BEQ33710148-5997B4A5-8016-4E93-B634-9770C23D3E43Q34183508-F76E6CDF-7549-4CB2-9873-397B0D0E53AAQ34206526-259003C3-6899-46CF-8DA5-8E237F352918Q34251665-7182641E-CC45-4417-9993-429788F94148Q34623350-361CE21B-6D91-43DC-9E0C-D7AAB79E7CEEQ35141115-716FC896-5A74-462C-8BB8-9B7F7A3148BBQ35144224-B8606F9C-6787-4AA6-A4C9-1652AD6AAD07Q35468850-7851F5F6-C821-47D8-AFC7-5B94EABEB7A5Q35787106-C15CCDDC-0136-4274-B94E-5F7EC91A3EF6Q36611720-E2794AB3-DCD1-4983-96F0-CBFE2C013FEFQ36621051-A313659A-EC74-4AD9-9316-7FF7CEF553B3Q36770024-125AC485-F4D1-4475-AD48-3AC0A9C5D140Q37162798-D5EA9515-E8FA-4F24-B8B4-B36B49C600DCQ37162821-0BB7F08C-0731-4A0C-BEE4-7294B7F6FCC7Q37246047-A60E4F50-4702-41EC-9BB0-113704436B40Q37739435-3A607CED-E1F0-4331-8356-0598353C1C28Q37822484-48DB071B-36BE-40CD-BBF7-C79934C825DCQ38091301-43250BB4-9155-4885-ADA0-FC973AE493C9Q38411525-17511988-5500-4CB6-B218-7F0C560AFABBQ38538492-7987BC24-5D51-434C-AF5D-2564481B4BBAQ38892075-C69FF057-973D-4F8B-B7E1-85892AEA52E0Q40011140-85311B60-4CAE-46D1-8870-305906F63CB7Q43813639-48F8464D-E6A4-4C8D-8638-55F0919F11A1Q43956859-C0E34506-3141-480E-96C3-ABCA3A56C0CCQ44786818-AF96226B-BA12-4EBF-8324-3094BC780002Q45297171-5EF7F378-6ED9-4561-BE93-57F70AE9A49EQ47133962-A2051CFC-4187-4ED5-87D7-1EF2977F82C1Q47136169-0359B1DF-D526-4124-868A-1D9A8A43E24DQ48533220-725D449A-12A0-4435-8F15-4ECADA83F3D1Q50591643-5670A0B7-69D0-452A-B473-8CC2D0C9DB92Q51887432-74B4A364-F8B5-4B68-95A0-89F2A5A6F1FCQ53439170-9A7555A0-D2E2-44C2-9707-24BBEE5FD24DQ57169390-DA5B3780-B68D-4EC1-8263-F9BD15938364Q58579097-C53F35E6-E01B-48A9-B112-CDA1F6D242BDQ58733645-755DCA80-AAD9-4ED8-91F1-CFA8B15CFB50Q58767549-D677F8AE-D1F2-446B-85C9-A3D1193B9D7A
P2860
Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Risk for cancer in a cohort of ...... phrenia in Denmark, 1969-1993.
@ast
Risk for cancer in a cohort of ...... phrenia in Denmark, 1969-1993.
@en
type
label
Risk for cancer in a cohort of ...... phrenia in Denmark, 1969-1993.
@ast
Risk for cancer in a cohort of ...... phrenia in Denmark, 1969-1993.
@en
prefLabel
Risk for cancer in a cohort of ...... phrenia in Denmark, 1969-1993.
@ast
Risk for cancer in a cohort of ...... phrenia in Denmark, 1969-1993.
@en
P50
P1476
Risk for cancer in a cohort of ...... ophrenia in Denmark, 1969-1993
@en
P2093
Lars Thomassen
P304
P356
10.1016/J.SCHRES.2004.11.009
P407
P577
2004-12-13T00:00:00Z